ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,086 | -21.1% | 199,360 | -2.9% | 0.00% | -50.0% |
| Q2 2023 | $1,377 | -24.1% | 205,287 | -0.1% | 0.00% | 0.0% |
| Q1 2023 | $1,814 | +16.1% | 205,485 | +0.4% | 0.00% | 0.0% |
| Q4 2022 | $1,563 | -99.9% | 204,588 | -46.3% | 0.00% | -50.0% |
| Q3 2022 | $2,711,000 | -7.3% | 380,817 | +5.3% | 0.00% | 0.0% |
| Q2 2022 | $2,926,000 | -11.0% | 361,734 | +52.7% | 0.00% | 0.0% |
| Q1 2022 | $3,286,000 | -90.6% | 236,870 | -80.9% | 0.00% | -89.2% |
| Q4 2021 | $34,835,000 | -12.6% | 1,241,506 | +5.9% | 0.04% | -17.8% |
| Q3 2021 | $39,844,000 | -14.5% | 1,172,276 | +2.7% | 0.04% | -13.5% |
| Q2 2021 | $46,622,000 | +23.7% | 1,141,054 | +21.9% | 0.05% | +13.0% |
| Q1 2021 | $37,683,000 | +11.3% | 936,014 | +63.4% | 0.05% | +7.0% |
| Q4 2020 | $33,869,000 | -6.7% | 572,793 | -23.2% | 0.04% | -15.7% |
| Q3 2020 | $36,289,000 | -5.2% | 746,246 | -5.7% | 0.05% | -13.6% |
| Q2 2020 | $38,269,000 | +84.4% | 791,014 | +5.9% | 0.06% | +55.3% |
| Q1 2020 | $20,748,000 | +701.4% | 746,896 | +763.0% | 0.04% | +850.0% |
| Q4 2019 | $2,589,000 | – | 86,550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |